Automated suturing devices sales will rise through 2036, driven by disposable devices at an 80.6% share, supported by infection control protocols and single-use regulatory mandates in surgical settings. Minimally invasive surgeries lead with a 75.8% share. The market is set to reach USD 3.8 billion by 2026-end and USD 7.5 billion by 2036.